Taiwan · Delayed Price · Currency is TWD Prince Pharmaceutical Statistics
Total Valuation
TPEX:6935 has a market cap or net worth of TWD 1.12 billion. The enterprise value is 1.48 billion.
| Market Cap | 1.12B |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6935 has 36.61 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 36.61M |
| Shares Outstanding | 36.61M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 7.82% |
| Owned by Institutions (%) | 12.50% |
| Float | 12.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | 36.78 |
| P/OCF Ratio | 27.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.80, with an EV/FCF ratio of 48.73.
| EV / Earnings | -135.65 |
| EV / Sales | 1.86 |
| EV / EBITDA | 22.80 |
| EV / EBIT | n/a |
| EV / FCF | 48.73 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.63 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 6.77 |
| Debt / FCF | 14.47 |
| Interest Coverage | 0.23 |
Financial Efficiency
Return on equity (ROE) is -1.47% and return on invested capital (ROIC) is 0.21%.
| Return on Equity (ROE) | -1.47% |
| Return on Assets (ROA) | 0.11% |
| Return on Invested Capital (ROIC) | 0.21% |
| Return on Capital Employed (ROCE) | 0.21% |
| Revenue Per Employee | 3.80M |
| Profits Per Employee | -52,095 |
| Employee Count | 210 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 4.38 |
Taxes
In the past 12 months, TPEX:6935 has paid 5.90 million in taxes.
| Income Tax | 5.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.74% in the last 52 weeks. The beta is 1.06, so TPEX:6935's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +24.74% |
| 50-Day Moving Average | 30.57 |
| 200-Day Moving Average | 26.93 |
| Relative Strength Index (RSI) | 49.82 |
| Average Volume (20 Days) | 16,955 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6935 had revenue of TWD 798.27 million and -10.94 million in losses. Loss per share was -0.30.
| Revenue | 798.27M |
| Gross Profit | 116.94M |
| Operating Income | 2.34M |
| Pretax Income | -5.04M |
| Net Income | -10.94M |
| EBITDA | 56.35M |
| EBIT | 2.34M |
| Loss Per Share | -0.30 |
Balance Sheet
The company has 76.85 million in cash and 440.71 million in debt, with a net cash position of -363.86 million or -9.94 per share.
| Cash & Cash Equivalents | 76.85M |
| Total Debt | 440.71M |
| Net Cash | -363.86M |
| Net Cash Per Share | -9.94 |
| Equity (Book Value) | 740.69M |
| Book Value Per Share | 20.23 |
| Working Capital | 155.74M |
Cash Flow
In the last 12 months, operating cash flow was 40.47 million and capital expenditures -10.01 million, giving a free cash flow of 30.45 million.
| Operating Cash Flow | 40.47M |
| Capital Expenditures | -10.01M |
| Free Cash Flow | 30.45M |
| FCF Per Share | 0.83 |
Margins
Gross margin is 14.65%, with operating and profit margins of 0.29% and -1.37%.
| Gross Margin | 14.65% |
| Operating Margin | 0.29% |
| Pretax Margin | -0.63% |
| Profit Margin | -1.37% |
| EBITDA Margin | 7.06% |
| EBIT Margin | 0.29% |
| FCF Margin | 3.81% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.82%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.82% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.34% |
| Shareholder Yield | 0.48% |
| Earnings Yield | -0.98% |
| FCF Yield | 2.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6935 has an Altman Z-Score of 1.57 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 7 |